83 related articles for article (PubMed ID: 8622627)
1. Role of c-jun in human myeloid leukemia cell apoptosis induced by pharmacological inhibitors of protein kinase C.
Freemerman AJ; Turner AJ; Birrer MJ; Szabo E; Valerie K; Grant S
Mol Pharmacol; 1996 May; 49(5):788-95. PubMed ID: 8622627
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C.
Jarvis WD; Turner AJ; Povirk LF; Traylor RS; Grant S
Cancer Res; 1994 Apr; 54(7):1707-14. PubMed ID: 7511048
[TBL] [Abstract][Full Text] [Related]
3. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
[TBL] [Abstract][Full Text] [Related]
4. Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C.
Grant S; Turner AJ; Bartimole TM; Nelms PA; Joe VC; Jarvis WD
Oncol Res; 1994; 6(2):87-99. PubMed ID: 7949469
[TBL] [Abstract][Full Text] [Related]
5. Effect of novel modulators of protein kinase C activity upon chemotherapy-induced differentiation and apoptosis in myeloid leukemic cells.
Meinhardt G; Eppinger E; Schmidmaier R
Anticancer Drugs; 2002 Aug; 13(7):725-33. PubMed ID: 12187329
[TBL] [Abstract][Full Text] [Related]
6. Activation of p38 and c-Jun N-terminal kinase pathways and induction of apoptosis by chelerythrine do not require inhibition of protein kinase C.
Yu R; Mandlekar S; Tan TH; Kong AN
J Biol Chem; 2000 Mar; 275(13):9612-9. PubMed ID: 10734112
[TBL] [Abstract][Full Text] [Related]
7. Evidence that the apoptotic actions of etoposide are independent of c-Jun/activating protein-1-mediated transregulation.
Jarvis WD; Johnson CR; Fornari FA; Park JS; Dent P; Grant S
J Pharmacol Exp Ther; 1999 Sep; 290(3):1384-92. PubMed ID: 10454518
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis of human glioma cells in response to calphostin C, a specific protein kinase C inhibitor.
Ikemoto H; Tani E; Matsumoto T; Nakano A; Furuyama J
J Neurosurg; 1995 Dec; 83(6):1008-16. PubMed ID: 7490614
[TBL] [Abstract][Full Text] [Related]
9. Evidence against a direct role for the induction of c-jun expression in the mediation of drug-induced apoptosis in human acute leukemia cells.
Bullock G; Ray S; Reed J; Miyashita T; Maria Ibrado A; Huang Y; Bhalla K
Clin Cancer Res; 1995 May; 1(5):559-64. PubMed ID: 9816016
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C inhibition induces apoptosis and ceramide production through activation of a neutral sphingomyelinase.
Chmura SJ; Nodzenski E; Weichselbaum RR; Quintans J
Cancer Res; 1996 Jun; 56(12):2711-4. PubMed ID: 8665499
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of the kinase inhibitor chelerythrine on acetylcholine-induced current in PC12 cells.
Shi L; Wang Ca
Arch Biochem Biophys; 1999 Aug; 368(1):40-4. PubMed ID: 10415109
[TBL] [Abstract][Full Text] [Related]
12. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis.
Grant S; Turner AJ; Freemerman AJ; Wang Z; Kramer L; Jarvis WD
Exp Cell Res; 1996 Oct; 228(1):65-75. PubMed ID: 8892972
[TBL] [Abstract][Full Text] [Related]
13. Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells.
Ritke MK; Rusnak JM; Lazo JS; Allan WP; Dive C; Heer S; Yalowich JC
Mol Pharmacol; 1994 Oct; 46(4):605-11. PubMed ID: 7969039
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo activity of protein kinase C inhibitor chelerythrine chloride induces tumor cell toxicity and growth delay in vivo.
Chmura SJ; Dolan ME; Cha A; Mauceri HJ; Kufe DW; Weichselbaum RR
Clin Cancer Res; 2000 Feb; 6(2):737-42. PubMed ID: 10690561
[TBL] [Abstract][Full Text] [Related]
15. Synergistic stimulatory effect of 12-O-tetradecanoylphorbol-13-acetate and capsaicin on macrophage differentiation in HL-60 and HL-525 human myeloid leukemia cells.
Zheng X; Ryan A; Patel N; Klemons S; Hansson A; Shih WJ; Lin Y; Huberman E; Chang RL; Conney AH
Int J Oncol; 2005 Feb; 26(2):441-8. PubMed ID: 15645129
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of protein kinase C translocation from cytosol to membrane by chelerythrine.
Chao MD; Chen IS; Cheng JT
Planta Med; 1998 Oct; 64(7):662-3. PubMed ID: 9810275
[TBL] [Abstract][Full Text] [Related]
17. Induction of c-fos and c-jun mRNA expression by basic fibroblast growth factor in cultured rat Müller cells.
Cao W; Li F; Steinberg RH; LaVail MM
Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):565-73. PubMed ID: 9501868
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53.
Vrana JA; Decker RH; Johnson CR; Wang Z; Jarvis WD; Richon VM; Ehinger M; Fisher PB; Grant S
Oncogene; 1999 Nov; 18(50):7016-25. PubMed ID: 10597302
[TBL] [Abstract][Full Text] [Related]
19. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C beta gene expression is associated with susceptibility of human promyelocytic leukemia cells to phorbol ester-induced differentiation.
Tonetti DA; Horio M; Collart FR; Huberman E
Cell Growth Differ; 1992 Oct; 3(10):739-45. PubMed ID: 1445803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
